The largest database of trusted experimental protocols

11 protocols using gene synthesis

1

Generation and Characterization of Dll1 and Dll4 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untagged Dll1 and Dll4 ORFs were PCR-amplified with primer pairs Dll1-for (SpeI) ACT AGT GCC ACC ATG TCT TAC GGT CAA GGG TCC AGC / Dll1-rev (AseI) GAT CAT TAA TTC ACA CCT CAG TCG CTA TAA CAC ACT CAT CCT TTT C and Dll4-for (NheI) GCT AGC AAT TCA TGA CGC CTG CGT CCC G / Dll4-rev (NdeI) CAT ATG TTA TAC CTC TGT GGC AAT CAC. Restriction sites introduced via primers were used to insert PCR products into NheI-NdeI sites of a shuttle vector containing IRES-GFP. Dll-IRES-GFP constructs were then subcloned into pMP8.CAG-Stop using restriction enzymes SwaI and MluI. HA-tagged versions of the above constructs for quantification of protein levels (Fig 1D) were cloned in a similar way: PCR primers for Dll1-HA were Dll1-for (SpeI; see above) / Dll1-HA-rev (AseI) ATT AAT CTA AGC GTA ATC TGG AAC ATC GTA TGG GTA CAT ACT AGA CAC CTC AGT CGC TAT AAC ACA C. A C-terminal HA-tag was introduced to the Dll4 ORF via gene synthesis (Life technologies) of the flanking regions of Dll4-HA lacking the central AflII/EcoRV Dll4 fragment that was cloned into the synthesised fragment; the complete Dll4-HA was cloned into NheI/NdeI of the shuttle vector. HA-tagged constructs were Cre-recombined in bacteria of the recombination strain SW106 (NCI at Frederick).
+ Open protocol
+ Expand
2

Generation and Cloning of Bacterial Deubiquitinases

Check if the same lab product or an alternative is used in the 5 most similar protocols
Generation of Salmonella Typhimurium SseL, Chlamydia trachomatis ChlaDUB1, Escherichia coli ElaD, Shigella flexneri ShiCE, Rickettsia bellii RickCE, Legionella pneumophila LegCE, Yersinia pestis YopJ, and Salmonella Typhimurium AvrA constructs was described previously11 (link). Sequences for Chlamydia trachomatis ChlaDUB2 and Chlamydia abortus ChlaDUB were obtained via gene synthesis (Life Technologies). Following amplification with KOD polymerase (EMD Millipore), the genes were inserted into the pOPIN-B or pOPIN-GFP vector30 (link) with the In-Fusion cloning method (Takara Bio USA). All mutagenesis was performed using the Quikchange method (Agilent).
+ Open protocol
+ Expand
3

Lentiviral production of GC-C variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
GC-C sequences were downloaded from GenBank based on whole genome sequences from each species tested. Each C-terminally HA tagged GC-C variant was synthesized via gene synthesis (Life Technologies). GC-C was then cloned into the lentiviral transfer vector pUltra (Addgene #24129) between the XbaI and BamHI restriction sites by Gibson Assembly, in frame with GFP and the T2A linker sequence. To generate lentiviral particles, 10 cm dishes were seeded with 3 × 106 293T cells 24 hours prior to transfection. Cells were then transfected with 7.6 μg pUltra-GC-C, 7.6 μg psPAX2 packaging plasmid (Addgene # 12260), and 3.8 μg pMD2.G envelope plasmid (Addgene # 12259) with 56 μl FuGene HD transfection reagent according to the manufacturer’s specifications. Media was replaced 24 hours post-transfection and replaced with 10 mL media. Viral supernatants were collected 48 hours-post transfection and passed through a 0.4 μm followed by overnight incubation with 1X PEG-IT solution (System Biosciences) at 4°C. Precipitated viral particles were centrifuged at 1500xg for 30 min at 4°C and resuspended in PBS at a final volume of 500 μl before storage at −80°C.
+ Open protocol
+ Expand
4

Preparation of Trastuzumab-Based Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The trastuzumab- and trastuzumab-IFN-β mutein-expressing gene constructs were generated by gene synthesis (Cosmogenetech, Seoul, Korea), and the synthesized heavy and light chain DNAs were inserted into the pCHO 1.0 expression vector (Life Technologies, Gaithersburg, MD, United States) at the AvrII-Bstz17I and EcoRV-PacI sites of the polylinker region, respectively (Supplementary Table S1). CHO-S cells (Life Technologies, Gaithersburg, MD, United States) were transfected with the expression vectors, and stable clones were selected with 100–10,000 nM of methotrexate (Sigma, NY, United States) and 10–50 μg/ml of puromycin (Life Technologies, Gaithersburg, MD, United States). Culture media from CHO-S cells stably expressing trastuzumab and trastuzumab-IFN-β muteins were collected and loaded onto a MabSelect SuReTM rProtein A agarose-bead resin (GE Healthcare, WI, United States), and the proteins were eluted using 0.1 M sodium citrate buffer (pH 3.0). The purified antibody and antibody-cytokine fusion proteins were quantified using the Cedex Bio Analyzer (Roche, Indianapolis, IN, United States) and analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing and non-reducing conditions.
+ Open protocol
+ Expand
5

Cloning of hCMV iE1 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cDNAs encoding hCMV iE11–328 and iE11–289 fused to an N-terminal FLAG tag were obtained by gene synthesis (Integrated DNA Technologies, Inc.) and then cloned into the pCDNA.3 vector (Invitrogen) (pCDNA3-FLAG-hCMV iE11–382 [BUG 3779; Bacteria-Cell Interactions laboratory's bacteria collection] and pCDNA3-FLAG-hCMV iE11–289 [BUG 3780]). The plasmids encoding YFP-CBD, a yellow fluorescent protein (YFP) chimera protein of the cell wall binding domain (CBD) from the Listeria phage endolysin Ply118 (BUG 2305; kind gift from J. Swanson, University of Michigan Medical School, Ann Arbor, MI, USA), and Sp100 (pSG5-Sp100WT [BUG 4134] and its derivative pSG5-Sp100K297R [BUG 4135]) have been described previously (11 (link), 57 (link)).
+ Open protocol
+ Expand
6

Plasmid Constructs for FMDV Protease and LGP2 Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids encoding the WT or C51A mutant Lb protease were generated by PCR amplification of the corresponding regions from an FMDV O1K full-length cDNA clone [46 (link)] and insertion into the BamHI and XbaI sites of pcDNA3.1(+) (Invitrogen). Plasmids encoding the sequence of porcine LGP2 with a C-terminal Myc tag and/or an N-terminal DDK tag were generated by gene synthesis (NZYTech) and cloning into the NheI and XbaI sites of pcDNA3.1(+) (Invitrogen). Plasmid encoding (C-terminal Myc-DDK-tagged)-human LGP2 was from Origen. Plasmid pcDNA3/Flag-METTL3 encoding human methyltransferase-like 3 was from Addgene (# 53739).
For transfection, 2 μg of LGP2-encoding plasmids and 1 μg of plasmids encoding FMDV proteases were used using Lipofectamine 2000 (Invitrogen) following the manufacturer's recommendations. The total amount of transfected DNA was balanced to 3 μg with empty vector. In some experiments, the transfection medium was supplemented with 20 μM Puromycin (apoptosis inducer, Sigma-Aldrich), 20 μM zVAD-FMK (broad caspase inhibitor, Promega) or 10 μM MG132 (proteasome inhibitor, Cayman Chemical).
+ Open protocol
+ Expand
7

Generation of Expression Plasmids for Pou5 Rescue Experiment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression plasmids carrying Pou5 coding sequences (CDS) were generated for ZHBTc4 ESC rescue experiment by inserting the triple flag-tagged (3xflag) Pou5 coding sequences into pCAGIP vector43 (link),69 (link) between the CAG promoter and the IRES-PAC (Puromycin resistant gene encoding puromycin N-acetyl-transferase). The sources of Pou5 genes used for the rescue assay are listed in Supplementary Data 2. Pou5 CDS for CpP1, CpP3, EbP5, LcP1, LcP3, LeP1, LeP3, MeP1, MeP3, RtP1, RtP3, ScP3 and chimeric constructs S313, EbP5LH2 and EbP5S4LH2 were synthesised by gBlock (IDT) and Gene synthesis (Invitrogen) services. XhoI/NotI sites were used to insert Pou5 fragments into the pCAG 3xflag mOct4 vector in replace of the mouse Oct4 CDS. For LcP1, AmP1, AmP3 with XhoI sites present in the CDS, GeneArt® Seamless Cloning & Assembly (Invitrogen) was used to subclone the Pou5 CDS into pUCL19 carrying a 3xflag sequence. The 3xflag Pou5 CDS were then inserted by transfer a XbaI/NotI fragment into the same sites in the pCAG vector. DNA sequencing was performed by GATC Biotech.
+ Open protocol
+ Expand
8

Generation and Purification of Fab-fragments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monomeric Fab-fragments originating from monoclonal antibodies were generated by gene synthesis (Invitrogen, Carlsbad, California) or by PCR-based cloning of the variable region from hybridomas as previously described [16] . In brief, the obtained variable sequences were fused with constant domains of human subclass IgG1/k with the heavy chains carboxy-terminally fused with a Streptag affinity tag and verified by sequencing. All combinatorial cloning was done using the StarGate cloning system (IBA, Göttingen, Germany) with fusion vectors adapted for Fab expression. For affinity modulation of the generated Fab-fragments mutagenesis PCR was applied to introduce targeted amino acid substitutions. Following cloning, the Streptag fusion proteins were periplasmatically expressed in E. coli K-12 strain JM83 and subsequently purified from periplasmic extracts by Strep-tag/Strep-Tactin affinity chromatography via a StrepTactin Superflow column (IBA) and stored in PBS pH 7.5.
+ Open protocol
+ Expand
9

Recombinant CCN Fusion Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitous chromatin opening elements-CMV plasmid expression vectors encoding fusion protein with full-length CCN5 (HHS-CCN5(FL)), fusion proteins with the TSP1 homology domain of CCN5 (HHS-CCN5(III) or Alb-CCN5(III)) or CCN3 (Alb-CCN3(III)), or the HHS fusion partner (HHS) alone were generated by recombination cloning using the Gateway cloning system. The expression vectors also encoded dihydrofolate reductase allowing selection pressure with methotrexate. Maps of the expression vectors with inserts are shown in Fig. S1, A and B. Inserts were codon-optimized for expression in hamster cells and synthesized as “DNA strings” or “gene synthesis” (Thermo Fisher Scientific). DNA string constructs were verified by DNA sequencing (Eurofins Genomics), and DNA sequences of constructs generated by gene synthesis were verified by the manufacturer.
+ Open protocol
+ Expand
10

Codon-Optimized BHAC Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
BHAC genes were codon optimized for expression in A. thaliana by gene synthesis (ThermoFisher Scientific) and matured for golden-gate cloning. All plasmids were generated with the MoClo tool kit, including vector backbones and genetic parts (51 (link)). Plasmids were sequenced by Sanger sequencing (Microsynth). Plasmids and primers used in this study are listed in SI Appendix, Tables S1 and S2, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!